Although the revenue and EPS for UnitedHealth (UNH) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
For the third quarter, UnitedHealth reported adjusted earnings per share of $2.92 compared with $7.15 a year earlier. Revenue rose to $113.2 billion from $100.8 billion.
UnitedHealth Group NYSE: UNH has staged a formidable comeback, with its stock up over 29% in the last 90 days as investors embraced management's aggressive turnaround strategy. This powerful rally has built high expectations, and the market now looks to UnitedHealth Group's third-quarter earnings report on Oct. 28 for the proof needed to sustain the momentum.
UnitedHealth (UNH)'s stock jumped 31% in three months, driven not only by a slight increase in revenue and a high P/E multiple, but also amid mixed signals: a Q2 earnings miss, regulatory scrutiny, and renewed investments in AI. What's behind this volatility?
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth: Bargaining Power And Tariff-Driven Generics Could Improve Margins
In the most recent trading session, UnitedHealth Group (UNH) closed at $356.67, indicating a -1.24% shift from the previous trading day.
UnitedHealth Group (UNH) faces major headwinds, including regulatory changes, mispricing, rising care costs, and DOJ investigations, but remains a healthcare leader. UNH is aggressively repricing plans, expanding value-based care, and implementing AI to address margin pressures and operational inefficiencies. Leadership changes signal a determined turnaround effort, with insider buying and superinvestor interest underscoring confidence in UNH's recovery.
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
In the latest trading session, UnitedHealth Group (UNH) closed at $354.5, marking a -3.59% move from the previous day.
A UnitedHealth Group affiliate plans to acquire a Boston-area primary care group called Acton Medical Associates, Bloomberg reported Thursday (Oct. 9), citing a notice posted by the Massachusetts Health Policy Commission. Atrius Health, an affiliate of UnitedHealth Group's Optum division, has agreed to acquire the 45-doctor medical practice, according to the report.
UnitedHealth drives a digital overhaul at Optum Rx, automating pharmacy workflows to boost efficiency and enrich patient care.